Fractyl Health Inc (NASDAQ: GUTS) kicked off on Monday, up 5.41% from the previous trading day, before settling in for the closing price of $1.85. Over the past 52 weeks, GUTS has traded in a range of $1.74-$14.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 96.33%. With a float of $20.64 million, this company’s outstanding shares have now reached $48.09 million.
In terms of profitability, gross margin is -47.42%, operating margin of -83816.49%, and the pretax margin is -64849.48%.
Fractyl Health Inc (GUTS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fractyl Health Inc is 57.09%, while institutional ownership is 35.96%. The most recent insider transaction that took place on Nov 11 ’24, was worth 238,358. In this transaction Chief Executive Officer of this company sold 96,517 shares at a rate of $2.47, taking the stock ownership to the 491,329 shares. Before that another transaction happened on Nov 11 ’24, when Company’s President, Chief Product Off. sold 64,197 for $2.47, making the entire transaction worth $158,541. This insider now owns 153,544 shares in total.
Fractyl Health Inc (GUTS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 96.33% per share during the next fiscal year.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Take a look at Fractyl Health Inc’s (GUTS) current performance indicators. Last quarter, stock had a quick ratio of 5.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 937.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.16, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -2.55 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
The latest stats from [Fractyl Health Inc, GUTS] show that its last 5-days average volume of 0.58 million was superior to 0.49 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 15.59%. Additionally, its Average True Range was 0.19.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 10.15%, which indicates a significant decrease from 39.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.04% in the past 14 days, which was lower than the 92.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2218, while its 200-day Moving Average is $3.9594. Now, the first resistance to watch is $2.1000. This is followed by the second major resistance level at $2.2500. The third major resistance level sits at $2.4000. If the price goes on to break the first support level at $1.8000, it is likely to go to the next support level at $1.6500. Assuming the price breaks the second support level, the third support level stands at $1.5000.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
The company with the Market Capitalisation of 93.79 million has total of 48,099K Shares Outstanding. Its annual sales at the moment are 120 K in contrast with the sum of -77,090 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -23,170 K.
